Boston Scientific Corporation
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of New York on behalf of those who acquired Boston Scientific Corporation (“Boston Scientific” or the “Company”) (NYSE: BSX) between April 24, 2019 and November 16, 2020, inclusive (the "Class Period"). Investors have until February 3, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
According to the Complaint, the Company made false and misleading statements to the market. Boston Scientific's LOTUS Edge Aortic Valve System suffered from a dysfunctional product delivery system which the viability of the entire product line at risk. The Company overstated the continued profitability of the LOTUS system. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Boston Scientific, investors suffered damages.
If you acquired Boston Scientific Corporation securities, have information, or would like to learn more about these claims, please contact Thomas W. Elrod of Kirby McInerney at 212-371-6600, by email at firstname.lastname@example.org, or by filling out this contact form, to discuss your rights or interests with respect to these matters without any cost to you.